Amplify Weight Loss Drug & Treatment ETF (THNR)
NYSEARCA: THNR · Real-Time Price · USD
25.97
+0.22 (0.84%)
Jul 28, 2026, 10:51 AM EDT - Market open
THNR Holdings Information
THNR is an equity ETF with a total of 23 individual holdings. The top holdings are Novo Nordisk stock at 9.95%, Eli Lilly and Company at 9.21%, Innovent Biologics at 5.49%, CSPC Pharmaceutical Group at 5.45%, and AbbVie at 5.37%.
Total Holdings
23
Top 10 Percentage
61.20%
Asset Class
Equity
ETF Category
Health
Assets
5.09M
PE Ratio
17.85
Breakdown by Country
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | NVO | Novo Nordisk A/S | 9.95% |
| 2 | LLY | Eli Lilly and Company | 9.21% |
| 3 | HKG: 1801 | Innovent Biologics, Inc. | 5.49% |
| 4 | HKG: 1093 | CSPC Pharmaceutical Group Limited | 5.45% |
| 5 | ABBV | AbbVie Inc. | 5.37% |
| 6 | ARWR | Arrowhead Pharmaceuticals, Inc. | 5.35% |
| 7 | REGN | Regeneron Pharmaceuticals, Inc. | 5.14% |
| 8 | SWX: ROP | Roche Holding AG | 5.12% |
| 9 | AMGN | Amgen Inc. | 5.08% |
| 10 | MRK | Merck & Co., Inc. | 5.05% |
| 11 | SRRK | Scholar Rock Holding Corporation | 4.96% |
| 12 | VKTX | Viking Therapeutics, Inc. | 4.91% |
| 13 | HIMS | Hims & Hers Health, Inc. | 4.53% |
| 14 | PFE | Pfizer Inc. | 4.49% |
| 15 | LON: AZN | AstraZeneca PLC | 4.44% |
| 16 | TYO: 4519 | Chugai Pharmaceutical Co., Ltd. | 4.34% |
| 17 | CPH: ZEAL | Zealand Pharma A/S | 3.51% |
| 18 | JNGHF | Jiangsu Hengrui Pharmaceuticals Co.,Ltd | 2.14% |
| 19 | KRX: 128940 | Hanmi Pharm. Co., Ltd. | 2.09% |
| 20 | KLRA | Kailera Therapeutics, Inc. | 1.98% |
| 21 | AGPXX | Invesco Short-Term Investments Trust Government & Agency Portfolio Institutional Class | 1.21% |
| 22 | n/a | OTHER ASSETS AND LIABILITIES | 0.20% |
| 23 | n/a | US DOLLARS | 0.00% |
As of Jul 23, 2026